Aricept Articles
Enrollment continues in Voyager's Ph III AD trial
24 April 2006
Increased mortality in Aricept VaD trial cohort
27 March 2006
Japan stock market week to March 6, 2006
13 March 2006
Japan recalculates eight drug ingredients due to high sales
27 February 2006
Japan stock market week to Feb 20, 2006
27 February 2006
Japan stock market week to Feb 6, 2006
13 February 2006
NICE disappoints in ruling on Alzheimer's
30 January 2006
Japan stock market 3 weeks to Jan 2, 2006
9 January 2006
Japan stock market week to Dec 12
19 December 2005
Japan stock market week to Sept 12
19 September 2005
Eisai applies to FDA for AD drug Aricept
12 September 2005
Aricept and Aciphex lead Eisai's growth
15 August 2005
Japan stock market week to August 1
8 August 2005
Japan stock market week to July 25
1 August 2005
Japan stock market week to May 30
6 June 2005
Aricept and Aciphex boost Eisai results
6 June 2005
Japan stock market week to May 23
30 May 2005
Japan stock market week to April 25
26 April 2005
Encouraging data for Lundbeck's Ebixa in AD
21 March 2005
UK NICE seeks to curb Alzheimer's drugs
7 March 2005
Tentative FDA appro for Ranbaxy's donepezil
7 March 2005
Aricept boosts Eisai's nine month results
28 February 2005
Japan stock market week to February 7
14 February 2005
Eisai signs deal with Cardinal for US sales
7 February 2005
Japan stock market week to January 17
24 January 2005
AD drugs for adults with brain injury?
24 January 2005
Eisai moves to ensure US drug availability
24 January 2005
Eisai 1st-half sales on target, rising 5.3%
15 November 2004
Tokyo pharma stocks - week to November 1
8 November 2004
Tokyo pharma stocks - week to October 25
1 November 2004
1st-qtr turnover rises 5.2% at Eisai
9 August 2004
Tokyo pharma stocks - week to August 2
9 August 2004
Eisai launches new US CNS sales force
9 August 2004
Stock Commentary - Tokyo
5 July 2004
Eisai/Pfizer's Alzheimer's disease drug Aricept is not cost-effective, says Lancet study
5 July 2004
Tokyo pharma stocks - week to june 28
5 July 2004
Tokyo pharma stocks - week to June 21
28 June 2004
Tokyo pharma stocks - week to May 31
7 June 2004
Overseas sales boost Eisai's results
31 May 2004
Tokyo pharma stocks - week to May 17
24 May 2004
Tokyo pharma stocks - week to April 26
3 May 2004
Eisai retains its fiscal 2003-2007 forecasts
8 March 2004
Eisai ups Aricept 2004 target on stellar 9 mths
23 February 2004
Tokyo pharma stocks - week to Feb 9
16 February 2004
Forest to seek wider approval of Namenda for Alzheimer's disease
19 January 2004
Tokyo pharma stocks - week to Jan 12
19 January 2004
Tokyo pharma stocks - week to Jan 5
5 January 2004
Eisai beats expectation in fiscal first half
24 November 2003
Tokyo pharma stocks - week to Nov 10
17 November 2003
Eisai/Pfizer's Aricept delays time to NHP
20 October 2003
Forest's Namenda on track for US approval
6 October 2003
Tokyo pharma stocks - week to August 4
11 August 2003
Eisai targets 20B yen Chinese sales
21 July 2003
Tokyo pharma stocks - week to July 7
14 July 2003
Stock Commentary - Tokyo
14 July 2003
Tokyo pharma stocks - week to June 2
9 June 2003
Eisai set to ramp up production
9 June 2003
Eisai beats forecasts on export growth
26 May 2003
Tokyo pharma stocks - week to May 19
26 May 2003
Teva and Eisai link up on CNS drug rasagiline
19 May 2003
Forest's memantine Ph III Alzheimer's trial
14 April 2003
S&P confirms Pfizer's AAA credit rating
24 February 2003
Tokyo pharma stocks - week to Jan 20
27 January 2003
Eisai looking to grow US field force by 60%
20 January 2003
Tokyo pharma stocks - week to Jan 13
20 January 2003
untitled
13 January 2003
Tokyo pharma stocks - 2 weeks to Dec 30
6 January 2003
Forest files revamped memantine NDA in USA
6 January 2003
Eisai ups US capacity for core products
6 January 2003
Aricept compliance better than Exelon?
19 August 2002
Aricept promising in stroke-induced dementia
29 July 2002
H3 Pharma starts trials of Alzheimer's drug
1 July 2002
Aricept for vascular dementia to be delayed
3 June 2002
Tokyo pharma stocks - week to May 20
27 May 2002
Tokyo pharma stocks - week to April 22
29 April 2002
Pfizer 1st-qtr EPS increases 18%
22 April 2002
Exelon has long-term benefit in Alzheimer's
15 April 2002
Head-to-head, Aricept superior to Reminyl
15 April 2002
Eisai expanding ties with rest of Asia
1 April 2002
Tokyo pharma stocks - week to March 4
11 March 2002
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
